1. Home
  2. APLS vs PLMR Comparison

APLS vs PLMR Comparison

Compare APLS & PLMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • PLMR
  • Stock Information
  • Founded
  • APLS 2009
  • PLMR 2013
  • Country
  • APLS United States
  • PLMR United States
  • Employees
  • APLS N/A
  • PLMR N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • PLMR Property-Casualty Insurers
  • Sector
  • APLS Health Care
  • PLMR Finance
  • Exchange
  • APLS Nasdaq
  • PLMR Nasdaq
  • Market Cap
  • APLS 2.9B
  • PLMR 2.9B
  • IPO Year
  • APLS 2017
  • PLMR 2019
  • Fundamental
  • Price
  • APLS $28.21
  • PLMR $113.30
  • Analyst Decision
  • APLS Buy
  • PLMR Buy
  • Analyst Count
  • APLS 19
  • PLMR 8
  • Target Price
  • APLS $33.63
  • PLMR $148.57
  • AVG Volume (30 Days)
  • APLS 2.4M
  • PLMR 284.4K
  • Earning Date
  • APLS 10-30-2025
  • PLMR 11-05-2025
  • Dividend Yield
  • APLS N/A
  • PLMR N/A
  • EPS Growth
  • APLS N/A
  • PLMR 49.38
  • EPS
  • APLS N/A
  • PLMR 5.68
  • Revenue
  • APLS $754,649,000.00
  • PLMR $682,205,000.00
  • Revenue This Year
  • APLS $24.62
  • PLMR $255.68
  • Revenue Next Year
  • APLS N/A
  • PLMR $19.34
  • P/E Ratio
  • APLS N/A
  • PLMR $19.94
  • Revenue Growth
  • APLS 20.02
  • PLMR 52.98
  • 52 Week Low
  • APLS $16.10
  • PLMR $85.00
  • 52 Week High
  • APLS $35.72
  • PLMR $175.85
  • Technical
  • Relative Strength Index (RSI)
  • APLS 64.41
  • PLMR 43.72
  • Support Level
  • APLS $23.85
  • PLMR $110.64
  • Resistance Level
  • APLS $25.73
  • PLMR $116.55
  • Average True Range (ATR)
  • APLS 1.28
  • PLMR 3.76
  • MACD
  • APLS 0.51
  • PLMR 0.04
  • Stochastic Oscillator
  • APLS 87.59
  • PLMR 25.05

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About PLMR Palomar Holdings Inc. Common stock

Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. provide insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The companies Earthquake product generate high premium.

Share on Social Networks: